Who
Denil Nanji Shekhat
Director
Company insider
Files Form 4 as: Director, MIRA Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 25 Mar 2024
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | MIRA MIRA PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $30K22,378 at $1.35 | filing |
| 9 Dec 2024filed 10 Dec 2024 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 25 Mar 2024filed 27 Mar 2024 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.